000048613 000__ 02238cam\a22004575i\4500
000048613 001__ 48613
000048613 003__ SzGeWIPO
000048613 005__ 20240205101134.0
000048613 006__ m    e   d        
000048613 008__ 231003s2023    sz ||||| |||||000|0 eng|d
000048613 0247_ $$2doi$$a10.34667/tind.48613
000048613 035__ $$aWIPO/PUB/RN2023-39/EN
000048613 035__ $$a(OCoLC)1412051880
000048613 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000048613 041__ $$aeng
000048613 1001_ $$aAbbott, Frederick M.,$$eauthor.
000048613 24510 $$aIntellectual Property and Technology Transfer for COVID-19 Vaccines :$$bAssessment of the Record.
000048613 264_1 $$aGeneva, Switzerland :$$bWorld Intellectual Property Organization,$$c2023.
000048613 300__ $$a116 pages ;$$c[28] cm
000048613 336__ $$atext$$btxt$$2rdacontent
000048613 337__ $$aunmediated$$bn$$2rdamedia
000048613 338__ $$avolume$$bnc$$2rdacarrier
000048613 4901_ $$aWIPO Publication ;$$vNo. RN2023-39
000048613 520__ $$aThe World Intellectual Property Organization (WIPO)’s Global Challenges Division commissioned an independent study on the role played by intellectual property (IP) and technology transfer in the development, production and distribution of vaccines used to address the COVID-19 pandemic. The study uses a case-study approach to provide an in-depth analysis of some of the different approaches adopted by ten different global vaccine manufacturers, with respect to their funding, procurement, vaccine development and IP strategies (including licensing, technology transfer and access provisions). These experiences and lessons learnt provide practical insights to guide global policy-making on IP, health and access issues.
000048613 542__ $$fCC BY 4.0
000048613 650_4 $$aPatents.$$zVaccines.
000048613 650_4 $$aIntellectual property.
000048613 650_4 $$aScience and technology.
000048613 650_4 $$aTechnology transfer.
000048613 650_0 $$aIntellectual property.
000048613 650_0 $$aPatents.
000048613 650_0 $$aTechnology transfer$$xLaw and legislation.
000048613 7101_ $$aWorld Intellectual Property Organization.
000048613 830_0 $$aWIPO Publication ;$$vNo. RN2023-39.
000048613 8564_ $$y10.34667/tind.48613$$s3677857$$uhttps://tind.wipo.int/record/48613/files/wipo-pub-rn2023-39-en-intellectual-property-and-technology-transfer-for-covid-19-vaccines-assessment-of-the-record.pdf$$91388bdc0-f045-45c4-803c-7a2d0e5ee0f2
000048613 901__ $$aWIPO/PUB/RN2023-39
000048613 902__ $$a48613_en
000048613 904__ $$aBook
000048613 909__ $$ooai:tind.wipo.int: 48613$$pWIPOPUB
000048613 909__ $$ooai:tind.wipo.int:48613$$pWIPOPUB
000048613 909CO $$ooai:tind.wipo.int:48613$$pWIPOPUB
000048613 980__ $$aWIPOPUB